<DOC>
	<DOCNO>NCT01253226</DOCNO>
	<brief_summary>This study evaluate safety tolerability multiple dos LY2127399 Japanese patient rheumatoid arthritis ( RA ) .The study consist 20 week treatment period . All subject follow 12 week last study drug administration .</brief_summary>
	<brief_title>A Study Japanese Patients With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Have give write informed consent Women must pregnant , breastfeed risk become pregnant study participation Diagnosis Rheumatoid Arthritis Active Rheumatoid Arthritis Current , regular use Methotrexate , stable dose Body weight 40 105 kg , inclusive Use exclude medication ( review study doctor ) Have medical finding , opinion study doctor , put patient unacceptable risk participation study Have recent ongoing infection , opinion study doctor put patient unacceptable risk participation Evidence tuberculosis Have systemic inflammatory condition RA</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>